MarginsXMarginsX
Home › Markets › Industrials › BRKR

Bruker Corporation (BRKR)

BRKR trades on Nasdaq in Industrials, Biotechnology: Laboratory Analytical Instruments. Numbers below come from the Nasdaq screener and SEC filings, each with its source.

Price · November 16, 2026
$60.62
-1.57% on the day
Market cap
$9.3B
Mid cap
Revenue · 2025
$3.4B
+2.1% on 2024
Net income · 2025
-$8.6M
-0.3% net margin

Price, change, market cap, sector and industry: Nasdaq stock screener, as of November 16, 2026. Revenue: SEC 10-K (us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax), fiscal year ended 2025-12-31, https://www.sec.gov/Archives/edgar/data/1109354/000119312526082523/0001193125-26-082523-index.htm. Net income: SEC 10-K (us-gaap:NetIncomeLoss), fiscal year ended 2025-12-31.

Profile

FieldValue
TickerBRKR on Nasdaq
SectorIndustrials
IndustryBiotechnology: Laboratory Analytical Instruments
CountryUnited States
IPO yearNot reported by the screener
SEC CIK0001109354
SEC industry codeLaboratory Analytical Instruments
Incorporated inDE

Financials · 2025

LineValue
Revenue$3.4B
Net income-$8.6M
Operating income$68.2M
Net margin-0.3%
Operating margin2.0%
Revenue growth+2.1%
Cash$298.8M
Total assets$6.2B
P/E (computed)Net income was not positive
P/S (computed)2.7×

Warning signs

Cash runway
Cash-flow positive
$119.7M cash at September 30, 2026
Share count, 1 year
+0.5%
2025-10-31 to 2026-11-02 · +10.3% over 3 years
Going-concern doubt
No
10-Q filed November 5, 2026
Insider net buying, 12 months
-$3.6M
Through September 30, 2026
SignFindingSource
Going concernNo going-concern finding.10-Q 2026-11-05
Cash and burn$119.7M cash; operating cash flow $85.5M a quarter.Report 2026-09-30
Shares outstanding152,722,385 (2026-11-02); 151,941,144 a year earlier; 138,411,212 three years earlier.Cover page 2026-11-02
Reverse splits, 3 yearsNone foundNone on EDGAR
Shelf and offerings, 12 months1 S-3/F-3 shelf filings; 0 424B5 takedownsLatest 2026-06-12
Exchange deficiency notices, 12 monthsNoneNone on EDGAR
AuditorPricewaterhouseCoopers LLP, Boston, Massachusetts, United StatesPCAOB Form AP 2026-03-18
Late filings, 12 monthsNoneNone on EDGAR
Insider trades, 12 monthsBought $0, sold $3.6M on the open marketSEC Forms 3/4/5 data sets 2026-09-30

From SEC EDGAR submissions, EDGAR full-text search, SEC's Forms 3/4/5 data sets and PCAOB Form AP; computed November 16, 2026. Runway is cash divided by average quarterly operating cash burn. Dilution compares cover-page share counts, corrected for recorded splits.

Quarterly results

QuarterRevenueNet incomeOp. cash flowCashTotal debtTTM revenueSource
Q3 2026
2026-09-30
$874.0M-$111.8M$118.2M$119.7M$1.7B$3.5B10-Q 2026-11-05
Q2 2026
2026-06-30
$838.5M-$52.0M-$77.4M$184.9M$1.8B$3.5B10-Q 2026-08-05
Q1 2026
2026-03-31
$823.4M$14.4M$71.2M$133.4M$1.7B$3.5B10-Q 2026-05-07
Q4 2025
2025-12-31
$977.2M$26.0M$229.8M$298.8M$1.9B$3.4B10-K 2026-02-27
Q3 2025
2025-09-30
$860.5M-$59.6M-$33.2M$293.1M$2.0B$3.4B10-Q 2026-11-05
Q2 2025
2025-06-30
$797.4M$7.6M-$127.5M$92.0M$2.4B$3.4B10-Q 2026-08-05
Q1 2025
2025-03-31
$801.4M$17.4M$65.0M$184.2M$2.1B$3.4B10-Q 2026-05-07
Q4 2024
2024-12-31
$979.6M$13.7M$190.0M$183.4M$2.1B$3.4B10-K 2026-02-27

From SEC XBRL company facts. Quarters a filing gives only as year-to-date are computed as differences (Q4 is the fiscal year minus nine months).

Key SEC documents

DocumentFormFiled
Latest prospectus or offering documentS-3ASR2026-06-12
Latest annual report10-K2026-02-27
Latest quarterly / interim10-Q2026-11-05
Latest current report8-K2026-11-16
Latest proxyDEFA14A2026-04-10

Source: SEC EDGAR submissions feed, 1,001 recent filings. All filings on EDGAR.

Price moves

WindowReturn
1 week+0.5%
1 month+9.6%
3 months+6.3%
Year to date+30.7%
1 year+47.4%
From 52-week high-7.4%

Source: Yahoo Finance daily closes, last bar 2026-11-13. Computed by MarginsX from daily closes; cap, sector and tier from the Nasdaq screener.

Other listings for this company

TickerNamePrice
BRKRPBruker Corporation 6.375% Mandatory Convertible Preferred Stock Series A$439.63

Peers in Biotechnology: Laboratory Analytical Instruments

TickerCompanyPriceDayMarket cap
BIOBio-Rad Laboratories Inc.$360.26-1.67%$9.7B
AVTRAvantor Inc.$15.32-1.42%$10.4B
TXG10x Genomics Inc.$54.99-5.50%$7.2B
RVTYRevvity Inc.$148.85-3.59%$16.6B
MTDMettler-Toledo International Inc.$1727.26-0.67%$34.4B
ALMRAlamar Biosciences Inc.$30.55-0.84%$2.1B
WATWaters Corporation$453.42-1.48%$44.6B
AAgilent Technologies Inc.$172.92-0.60%$48.8B

The full dossier has every filing, three years of financials, private raises and the people who signed them.

Open the full dossier